Randomized phase II trial of the anti-angiogenic potential...

Breast Cancer Research and Treatment 2005 / 01 Vol. 89; Iss. 2

Randomized phase II trial of the anti-angiogenic potential of doxorubicin and docetaxel; primary chemotherapy as Biomarker Discovery Laboratory

Kathy D. Miller, Sharon E. Soule, Cynthia Calley, Robert E. Emerson, Gary D. Hutchins, Kenyon Kopecky, Sunil Badve, AnnaMaria Storniolo, Robert Goulet, George W. Sledge
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
89
Language:
english
Pages:
11
DOI:
10.1007/s10549-004-2044-y
Date:
January, 2005
File:
PDF, 298 KB
english, 2005
Conversion to is in progress
Conversion to is failed